Diabetes Mellitus Type II Clinical Trial
Official title:
Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements
Vascular damage caused by diabetes mellitus, cigarette smoking, age and arterial hypertension theoretically changes pulse wave velocity.
Diabetes mellitus related vascular alterations are associated with an increased risk of
hypertonia, atherosclerosis, neuropathy, diabetic retinopathy, and further more.
Increased vascular rigidity, which is based on the increased stiffness of vessels caused by
vascular damage leads to an increase of pulse wave velocity. This assumption is based on the
Moens-Korteweg-equation which is calculated using the modus of arterial vessel elasticity,
arterial vessel wall thickness, the arterial radius and blood viscosity.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02261545 -
The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient
|
Phase 4 | |
Completed |
NCT01684813 -
VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel
|
Phase 4 | |
Completed |
NCT01252524 -
Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study
|
N/A | |
Recruiting |
NCT01311401 -
Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel
|
N/A | |
Completed |
NCT00563225 -
20 Week Bridging Study in Type II DM
|
Phase 3 | |
Recruiting |
NCT01565096 -
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
|
Phase 4 | |
Completed |
NCT00151697 -
LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
|
Phase 3 | |
Withdrawn |
NCT01453751 -
Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes
|
N/A | |
Not yet recruiting |
NCT01775059 -
Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
|
N/A | |
Completed |
NCT01281098 -
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
|
Phase 2 | |
Completed |
NCT01669473 -
A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use
|
N/A | |
Completed |
NCT02036372 -
Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
|
N/A | |
Completed |
NCT03258840 -
EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus
|
N/A | |
Active, not recruiting |
NCT01386801 -
Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
|
N/A | |
Completed |
NCT02144948 -
Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
|
Phase 3 |